ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.

Abstract	Large-scale genetic analyses of human tumor samples have been used to identify novel oncogenes, tumor suppressors and prognostic factors, but the functions and molecular interactions of many individual genes have not been determined. In this study we examined the cellular effects and molecular mechanism of the arrestin family member, ARRDC3, a gene preferentially lost in a subset of breast cancers. Oncomine data revealed that the expression of ARRDC3 decreases with tumor grade, metastases and recurrences. ARRDC3 overexpression represses cancer cell proliferation, migration, invasion, growth in soft agar and in vivo tumorigenicity, whereas downregulation of ARRCD3 has the opposite effects. Mechanistic studies showed that ARRDC3 functions in a novel regulatory pathway that controls the cell surface adhesion molecule, beta-4 integrin (ITGbeta4), a protein associated with aggressive tumor behavior. Our data indicates ARRDC3 directly binds to a phosphorylated form of ITGbeta4 leading to its internalization, ubiquitination and ultimate degradation. The results identify the ARRCD3-ITGbeta4 pathway as a new therapeutic target in breast cancer and show the importance of connecting genetic arrays with mechanistic studies in the search for new treatments.
Authors	K M Draheim, H-B Chen, Q Tao, N Moore, M Roche, S Lyle
Journal	Oncogene (Oncogene) Vol. 29 Issue 36 Pg. 5032-47 (Sep 09 2010) ISSN: 1476-5594 [Electronic] England
PMID	20603614 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References	ARRDC3 protein, human Arrestins Integrin beta4
Topics	Animals Arrestins (genetics, metabolism, physiology) Breast Neoplasms (genetics, metabolism, pathology) Carcinoma, Ductal, Breast (genetics, metabolism, pathology) Disease Progression Down-Regulation Female Genes, Tumor Suppressor (physiology) Humans Integrin beta4 (metabolism) Mice Mice, Nude Protein Processing, Post-Translational (genetics) Transfection Tumor Cells, Cultured Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!